Overview

A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
0
Participant gender:
All
Summary
This is a safety and efficacy study of fixed-combination bimatoprost and brimonidine compared with LUMIGAN® and ALPHAGAN® in patients with chronic glaucoma or ocular hypertension.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Brimonidine Tartrate
Ophthalmic Solutions
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Diagnosis of ocular hypertension or glaucoma

- Requires intraocular pressure (IOP)-lowering therapy

Exclusion Criteria:

- Cataract surgery in one eye

- Ocular laser or intraocular surgery within 6 months

- Refractive surgery in either eye

- Anticipated use of contact lenses during the study

- Expected use of artificial tears during the study